Skip to content

Drug interactions

Glyburide + Padeliporfin

Severity: Moderate

Glyburide and Padeliporfin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Padeliporfin may reduce hepatic uptake of glyburide through OATP inhibition, increasing exposure and the risk of hypoglycemia.

What this interaction means in plain words

Glyburide and Padeliporfin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Glyburide belongs to Endocrine; Padeliporfin belongs to Oncology.

Evidence level: Low

Why it happens

Inhibition of OATP1B1/1B3-mediated hepatic uptake of glyburide.

What to do

Avoid glyburide on the infusion day and for at least 24 hours after. Monitor blood glucose if exposure cannot be avoided.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Glyburide and Padeliporfin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Glyburide with Padeliporfin?

MediHelp rates the interaction as moderate. Glyburide and Padeliporfin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Padeliporfin may reduce hepatic uptake of glyburide through OATP inhibition, increasing exposure and the risk of hypoglycemia.

How serious is the interaction between Glyburide and Padeliporfin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid glyburide on the infusion day and for at least 24 hours after. Monitor blood glucose if exposure cannot be avoided.

What other medicines interact with Padeliporfin?

MediHelp also lists interactions of Padeliporfin with, for example, Acetylsalicylic acid, Amiodarone, Griseofulvin. The full list is on the Padeliporfin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in